Orphan designation: cusatuzumab Treatment of acute myeloid leukaemia, 22/04/2020 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 April 2024 - 14:16

Orphan designation: cusatuzumab Treatment of acute myeloid leukaemia, 22/04/2020 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2265

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters